Melanoma drug wins US approval. [electronic resource]
Producer: 20110525Description: 561 p. digitalISSN:- 1476-4687
- Antibodies, Monoclonal -- adverse effects
- Antigens, CD -- immunology
- Antineoplastic Agents -- immunology
- Antineoplastic Combined Chemotherapy Protocols
- CTLA-4 Antigen
- Clinical Trials as Topic
- Drug Approval
- Humans
- Immunotherapy -- methods
- Ipilimumab
- Melanoma -- drug therapy
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Survival Analysis
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.